Faculty Profile: Richard A. Brown, PHD

Richard A. Brown
Richard A. Brown, PHD
Professor of Psychiatry & Human Behavior
Psychiatry & Human Behavior
Work: +1 401-455-6254
My work has focused on development and evaluation of interventions for tobacco dependence and other substance use disorders. Research interests include: a) computer-, web- and smart phone-based interventions to promote translation/dissemination, b) social media interventions with adolescents for prevention of alcohol and drug abuse, c) distress tolerance and smoking lapse, d ) behavioral and pharmacological treatment of nicotine dependence, esp. with depression comorbidity, e) MI to reduce substance use in adolescents with psychiatric comorbidity, and f) physical activity interventions for individuals with substance use disorders.

Biography

Dr. Brown received his Ph.D. in clinical psychology from the University of Oregon in 1981, following completion of internship in clinical psychology at Brown Medical School. He remained at Brown in the Department of Family Medicine, until assuming the position of Assistant Professor at the Center of Alcohol Studies at Rutgers University from 1985-1986. He is currently Professor of Psychiatry and Human Behavior at the Alpert Medical School of Brown University and Director of Addictions Research at Butler Hospital in Providence, RI and has been an affiliated faculty member of the Brown Center for Alcohol and Addiction Studies since 1986. Dr. Brown has published over 130 scientific journal articles, books and book chapters. Dr. Brown has been Principal Investigator of 15 grants from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the National Cancer Institute and the American Cancer Society.

Institutions

Bh

Research Description

Richard A. Brown, Ph.D., is Professor of Psychiatry and Human Behavior at Brown Medical School and Director of Addictions Research at Butler Hospital. His clinical research in tobacco dependence includes the development of a nicotine fading procedure, which is still a mainstay of many behavioral treatment programs for smoking cessation. He is currently funded to develop and evaluate a brief, computer intervention for smokers in treatment for substance use disorders, to motivate them to engage in smoking cessation via tobacco quit line treatment. Current funding also includes evaluating the efficacy of an acceptance-based distress tolerance treatment for smoking cessation, and a placebo-controlled RCT to evaluate the efficacy of the sequential use of fluoxetine in combination with transdermal nicotine patch and behavioral counseling in smokers with elevated depressive symptoms.

Dr. Brown is also an active alcohol and drug addiction researcher and is engaged in developing a brief computer-based MI intervention to reduce adolescent substance use in teens with comorbid substance use and psychiatric disorders, which is derived from prior work with an efficacious, face-to-face MI intervention. He is also involved in research on the effectiveness of aerobic exercise as an intervention strategy for alcohol and drug recovery and for obsessive compulsive disorder. He has obtained research grants as Principal Investigator from the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Cancer Institute (NCI) and the American Cancer Society. He has over 125 publications in peer-reviewed scientific journals, and 12 book chapters and co-edited books.

Funded Research

GRANTS - Richard A. Brown, Ph.D.

1. Principal Investigator. Maximizing the rehabilitation of neurologically-impaired individuals: Improving family and community adjustment. Rhode Island Comprehensive Rehabilitation Center $11,977 total costs, 1982 - 1983.

2. Co-Principal Investigator. Psychosocial stressors, smoking cessation and coronary heart disease (with D. Abrams, PI). National Heart Blood and Lung Institute. 1RO1 HL28793, $266,000 total costs, 1982 - 1986.

3. Principal Investigator. Effects of coping skills training on psychological and physical functioning with chronic illness: Parkinson's disease. Bio-Medical Research Support Grant - National Institutes of Health (Pawtucket Memorial Hospital). $9,915 total costs, 1983 - 1984.

4. Principal Investigator. Coping with depression in smoking cessation. National Institute on Drug Abuse. 1RO1 DA-08511, $1,382,805 total costs, 1992 - 1996.

5. Principal Investigator. Coping with depression in smoking cessation. American Cancer Society. PBR -74, $305,000 total costs, 1992 - 1994. Funds reverted back to ACS in first (of three) year(s) of funding due to acquisition of NIDA grant (RO1 DA08511).

6. Co-Principal Investigator. Does health feedback enhance self-help smoking outcomes? (with K. Emmons, PI). National Heart, Blood and Lung Institute. 1RO1 HL48190, $725,626 total costs, 1992- 1996.

7. Principal Investigator. Efficacy of adding cognitive behavioral treatment of depression to alcohol treatment. Brown University Department of Psychiatry and Human Behavior, $17,600 total costs, 1993 - 1994.

8. Co-Investigator. Motivation and coping skills training for cocaine abuse (with D. Rohsenow, PI) National Institute on Drug Abuse. 2RO1 DA04859, $1,397,217, total costs, 1993 - 1997.

9. Co-Investigator. Coping, cue exposure & naltrexone treatment with alcoholics (with P. Monti, PI). National Institute on Alcohol Abuse and Alcoholism. 2 RO1 AA07850, $1,281,433 total costs, 1994 - 1999.

10. Co-Investigator. Motivation and patch treatment for underserved smokers (with R. Niaura, PI). National Cancer Institute/National Institute on Drug Abuse. 1RO1 DA10860, $1,400,000 total costs, 1996 - 1999.

11. Co-Investigator. Motivating alcoholics to quit smoking (with D. Abrams, PI). National Institute on Alcohol Abuse and Alcoholism. 1RO1 AA11211, $2,289,980 total costs, 1996 - 2001.

12. Co-Investigator. Cocaine craving and coping in treatment and relapse (with D. Rohsenow, PI). National Institute on Drug Abuse. 1RO1 DA11071, $745, 888 total costs, 1997 - 2001.

13. Principal Investigator. Expert system for teen depression in smoking cessation. Brown University Department of Psychiatry and Human Behavior, $10,000 total costs, 1997.

14. Co-Investigator. Matching antidepressant treatment for smoking cessation (with R. Niaura, PI). National Heart, Blood and Lung Institute. 3RO1 HL32318, $1,400,000 total costs, 1997 - 2001.

15. Principal Investigator. Coping with depression in smoking cessation. National Institute on Drug Abuse. 2RO1 DA-08511, $1,983,952 total costs, 1997 - 2001.

16. Principal Investigator. Efficacy of depression skills treatment with alcoholics. National Institute on Alcohol Abuse and Alcoholism. 1RO1 AA10958, $1,886,845 total costs, 1997 - 2001.

17. Principal Investigator. Smoking cessation in teens with comorbid psychopathology. National Cancer Institute. 1RO1 CA-77082, $1,847,469 total costs, 1997 - 2001.

18. Co-Investigator. Immunizing against tobacco use in pediatric health care (with R. Niaura, PI). National Cancer Institute. RO1 CA77010, $1,799,600 total costs, 1998 - 2002.

19. Co-Investigator. Nicotine dependence: Risk and recovery over generations (with D. Abrams, PI). National Cancer Institute. P50 CA84719, $11,582,454 total costs, 1999 - 2004.

20. Co-Investigator. Antidepressant treatment to reduce HIV risk among IDUs (with M. Stein, PI). National Institute of Mental Health. 1 RO1 MH61141, $1,216,314 total costs, 1999 -2003.

21. Principal Investigator. Behavioral vulnerability to early smoking lapse. National Cancer Institute. 1R21 CA88297, $362,500 total costs, 2000 - 2002.

22. Principal Investigator. Applying exercise intervention to drug treatment. National Institute on Drug Abuse. 1 RO1 DA14599, $826,072 total costs, 9/01 – 8/04.

23. Principal Investigator. Development of an exercise intervention for alcoholics. National Institute on Alcohol Abuse and Alcoholism. 1 RO1 AA13418, $618,696 total costs, 4/02 – 3/05.

24. Principal Investigator. Improving smoking cessation in smokers with depressive symptoms. American Cancer Society.. RSGPB-02-185-01-PBP. $1,355,000 total costs, 07/02 – 06/06.

25. Co-Investigator. Improving smoking cessation outcomes in heavy drinkers (with C. Kahler, PI). National Institute on Drug Abuse. 1 R01 DA015534, $1,646,117 total costs, 8/03 - 4/07.

26. Principal Investigator. Distress Tolerance Treatment for Early Smoking Lapsers. National Institute on Drug Abuse. 1 RO1 DA017332, $1,095,000 total costs, 9/03 - 7/06.

27. Principal Investigator. MI for Teen Substance Abuse with Psychiatric Comorbidity. National Institute on Drug Abuse. 1 RO1 DA016738, $2,514,565 total costs, 9/04 – 3/09.

28. Co-Investigator. Mood Management Phone Counseling in Smoking Cessation
(with D. Strong, PI). National Institute on Drug Abuse. 1 R01 DA017947, $985,550 total costs, 12-04 – 11/07.

29. Co-Investigator. Treatment for Suicide in Alcohol and Depressed Patients. (with I. Miller, PI). National Institute on Alcohol Abuse and Alcoholism. 1 R01 AA015950-01, $990,000 total costs, 1/06 – 12/08.

30. Co-Investigator. Development of a Treatment Adherence Program for Bipolar Substance Abusers. (with I. Miller, PI). National Institute on Drug Abuse. R01 DA023072, $967,140 total costs, 9/07 – 7/12.

31. Principal Investigator. MI for Teen Substance Abuse with Psychiatric Comorbidity. National Institute on Drug Abuse (Supplement). 3 RO1 DA016738-04S1, $71,996 total costs, 4/07 – 3/08.

32. Principal Investigator. Sequential Use of Fluoxetine for Smokers with Elevated Depressive Symptoms. National Institute on Drug Abuse. 1 RO1 DA023190, $2,374,108 total costs, 9/07 – 3/13.

33. Principal Investigator. Distress Tolerance Treatment for Smoking Cessation. National Institute on Drug Abuse. 2RO1DA017332-04A1, $1,319,459 total costs, 8/09 - 7/12.

34. Co-Investigator. Motivating Cessation Treatment Engagement in Depressed Inpatient Smokers (with D. Strong, PI). American Cancer Society. RSGPB-08-145-01- CPPB, $720,000 total costs, 7/01/08-6/30/11.

35. Co-Investigator. Testing the Efficacy of an Exercise Intervention for Patients with OCD
(with A. Abrantes, PI), National Institute of Mental Health. 1R01MH086513, $1,870,588 total costs, 7/10 – 3/14.

36. Co-Investigator. Development of Positive Psychotherapy for Smoking Cessation (with C. Kahler, PI). National Cancer Institute. 1RO1CA156241, $403,281 total costs, 1/11 – 12/12.

37. Co-Investigator. Distress Tolerance and Reducing Early Lapse in Buprenorphine Patients (with Michael Stein, PI), National Institute on Drug Abuse. 1R34DA032767, $556,966 total costs, 2/12 – 1/14.

38. Principal Investigator. Brief Computer Intervention to Motivate Quitline Use for Smokers in SUD Treatment, National Institute on Drug Abuse. 1R34DA034312-01, $595,557 total costs, 8/1/12 – 7/31/14.

39. Principal Investigator. Computer-based MI to engage smokers living with HIV in tobacco quitline treatment, National Institute on Drug Abuse. 1R34DA034558-01A1, $648,473 total costs, 4/1/13 – 3/31/15.

Teaching Experience

Dr. Brown is active in clinical and research supervision. For over 25 years, he has served as a primary clinical supervisor for clinical psychology interns and as a research supervisor for psychology interns and post-doctoral fellows in the Department of Psychiatry and Human Behavior (DPHB) at Brown Medical School. Dr. Brown is also an active contributor as a teacher in seminars for psychology interns and post-doctoral fellows in the DPHB and in the Brown Center for Alcohol and Addiction Studies.